Stanford's Multi-Agent Virtual Biotech System for Drug Development Published in Science
Stanford researchers published a multi-agent AI system called Virtual Biotech in Science, simulating a full biotech R&D organization with tens of thousands of AI agents that analyzed 57,000 clinical trials to find clues determining drug success or failure.
2026-09-25 ~ 2026-09-25 · 3 related posts
- Episode 1: Stanford's 37,000-Agent Virtual Biotech Discovers Potential Lung Cancer Drug(2026-09-20, 5 posts)
- Episode 2: Stanford's Virtual Biotech: 37,000 AI Agents Run a Virtual Pharma Company, Published in Science(2026-09-22, 6 posts)
- Episode 3: Stanford's Multi-Agent Virtual Biotech System for Drug Development Published in Science(2026-09-25, 3 posts)
- Stanford's 37K AI agents analyzed 57K clinical trials as a 'virtual biotech' — james_y_zou · 2026-09-25
- Stanford's Virtual Biotech runs 37,075 parallel AI-agent tasks to simulate drug R&D, published in Science — jiqizhixin · 2026-09-25
- Science study unveils Virtual Biotech, a multi-agent AI system for drug development — james_y_zou · 2026-09-25